The Venture Codex

Participated · Equity · May 2025

Imprint Labs is a New York City-based forensic immunology focused research organization building experimental and machine-learning tools to identify hidden causes and cures for chronic diseases. Led by CEO Beck Brachman and incubated by Cornell Tech, the company is developing methods to reconstruct immune histories from memory B cells and T cells at scale. Its stated approach aims to read the archive of immune exposures stored in memory immune cells to reveal diseases and hidden triggers. The company notes the immune repertoire signal is distributed, sparse, and constantly evolving, making it more difficult to resolve than the genome. Imprint plans to use the funds to advance work decoding the body’s immune memory and uncovering causes of chronic diseases. The article does not report operating metrics or prior financing details.